https://scholars.lib.ntu.edu.tw/handle/123456789/434768
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | CHIA-CHUAN CHANG | en_US |
dc.contributor.author | Yuan, W.; Roan, H.-Y.; Chang, J.-L.; Huang, H.-C.; Lee, Y.-C.; Tsay, H.J.; Liu, H.-K. | en_US |
dc.creator | Chia-Chuan Chang;Yuan, W.;Roan, H.-Y.;Chang, J.-L.;Huang, H.-C.;Lee, Y.-C.;Tsay, H.J.;Liu, H.-K. | - |
dc.date.accessioned | 2019-12-04T06:21:15Z | - |
dc.date.available | 2019-12-04T06:21:15Z | - |
dc.date.issued | 2016 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/434768 | - |
dc.description.abstract | Background: In this study, we aimed to develop a Stigmata Maydis (corn silk) fraction with dual bio-activities against oxidative stress and protein glycation to protect β-cells from diabetes-induced failure. Methods: Corn silk fractions were prepared by partition and chemically characterised by thin-layer chromatography. Free radical scavenging assay, glycation assay, and cell-based viability test (neutral red) were employed to decide the best fraction. Cell death analysis was executed by annexin V/ Propidium iodide staining. Cell proliferation was measured by WST-1. Finally, β-cell function was evaluated by β-cell marker gene expression (RT-PCR) and acute insulin secretion test. Results: Four corn silk fractions were prepared from an ethanolic crude extract of corn silk. In vitro assays indicate ethyl acetate fraction (YMS-EA) was the most potent fraction. YMS-EA also attenuated the hydrogen peroxide- or methylglyoxal-induced induction of reactive oxygen species, reduction of cell viability, and inhibition of cell proliferation. However, YMS-EA was unable to prevent hydrogen peroxide-induced apoptosis or advanced glycation end-products-induced toxicity. Under hyperglycemic conditions, YMS-EA effectively reduced ROS levels, improved mRNA expression of insulin, glucokinase, and PDX-1, and enhanced glucose-stimulated insulin secretion. The similarity of bioactivities among apigenin, luteolin, and YMS-EA indicated that dual activities of YMS-EA might be derived from those compounds. Conclusions: We concluded that YMS-EA fraction could be developed as a preventive food agent against the glucotoxicity to β-cells in Type 2 diabetes. ? 2016 The Author(s). | - |
dc.relation.ispartof | BMC Complementary and Alternative Medicine | - |
dc.subject | Advanced glycation end products; Glucotoxicity; Methylglyoxal; Reactive oxygen species; Stigmata Maydis (corn silk); β-cell failure | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | acetic acid ethyl ester; advanced glycation end product; aminoguanidine; antidiabetic agent; antioxidant; apigenin; corn silk fraction; glucokinase; herbaceous agent; hydrogen peroxide; insulin; luteolin; messenger RNA; metformin; methylglyoxal; reactive oxygen metabolite; transcription factor PDX 1; trolox C; unclassified drug; acetic acid derivative; advanced glycation end product; antioxidant; hydrogen peroxide; plant extract; reactive oxygen metabolite; animal cell; antioxidant activity; apoptosis; Article; cell proliferation; cell viability; controlled study; glucotoxicity; hyperglycemia; in vitro study; maize; nonhuman; oxidative stress; pancreas islet beta cell; protein glycosylation; rat; animal; cell line; cell survival; chemistry; drug effects; female; male; metabolism; mouse; Acetates; Animals; Antioxidants; Cell Line; Cell Survival; Female; Glycosylation End Products, Advanced; Hydrogen Peroxide; Male; Mice; Oxidative Stress; Plant Extracts; Rats; Reactive Oxygen Species; Zea mays | - |
dc.title | The ethyl acetate fraction of corn silk exhibits dual antioxidant and anti-glycation activities and protects insulin-secreting cells from glucotoxicity | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1186/s12906-016-1382-8 | - |
dc.relation.pages | 432 | - |
dc.relation.journalvolume | 16 | - |
dc.relation.journalissue | 1 | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.fulltext | no fulltext | - |
item.cerifentitytype | Publications | - |
item.openairetype | journal article | - |
item.grantfulltext | none | - |
crisitem.author.dept | Pharmacy | - |
crisitem.author.dept | School of Pharmacy | - |
crisitem.author.orcid | 0000-0002-1297-9602 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
顯示於: | 藥學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。